Drug

The White House effort to require reduced nicotine levels in cigarettes would upend the tobacco industry. Photo: Mario Tama/Getty Images…

Music can quite literally light up your whole brain. That’s because as the music plays into your ears, it taps into your emotions. This results in songs making you feel happy, sad, calm, angry, and even a slew of other emotional responses. What you might not have guessed, though, is that music can possibly act as a digital Alzheimer’s drug. And, if used correctly, it may help people suffering from the disease immensely. Music could act as a digital Alzheimer’s drug Image source: Sony/AmazonBorn Bonakdarpour, an…

An experimental drug is raising new hopes for those with Parkinson’s disease. So far, the compound has only been tested in animals and in an initial safety assessment in humans. But results show it inhibits a cellular pathway that gives rise to the disease, which researchers have been working to target for nearly 20 years. Investigators are now launching expanded clinical trials. “This is a very, very important step forward,” says Patrick Lewis, a neuroscientist who studies the…

Eli Lilly continues to work on commercializing its strong innovation pipeline, which is a key reason the CNBC Investing Club owns the stock. Eli Lilly continues to work on commercializing its strong innovation pipeline, which is a key reason the CNBC Investing Club owns the stock. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks…

In September 2020, a North Korean hacking group known as Lazarus broke into a small Slovakian crypto exchange and stole virtual currency worth some $5.4 million. It was one of a string of cyber heists by Lazarus that Washington said were aimed at funding North Korea's nuclear weapons programme. Several hours later, the hackers opened at least two dozen anonymous accounts on Binance, the world's largest cryptocurrency exchange, enabling them to convert the stolen funds and obscure the money trail, correspondence between…

The search for the root cause of neurodegenerative diseases like multiple sclerosis (MS) has turned up many suspects, but one central to many research efforts is a type of immune cell called microglia. The dysfunction of these key cogs in the central nervous system has prompted a wide-ranging search for drugs that can alter their activity, but new research suggests we might already have one such drug at our disposal, with an existing drug delivering significant therapeutic effects on experimental models of MS.Microglia…

A recently approved diabetes drug being clinically investigated for its effects on body weight in obese and overweight people has delivered "substantial and sustained reductions in body weight" in a phase 3 clinical trial, according to results now published in The New England Journal of Medicine.  Tirzepatide, developed by American pharmaceutical company Eli Lilly and Company (Lilly), is a once-weekly injection under the skin, originally developed for type 2 diabetes treatment.While not yet indicated for this use, it…

In what appears to be a very promising breakthrough for the treatment of rectal cancer, a small drug trial conducted in the US found every patient treated in the experiment had their cancer successfully go into remission.  The medication given, called dostarlimab and sold under the brand name Jemperli, is an immunotherapy drug used in the treatment of endometrial cancer, but this was the first clinical investigation of whether it was also effective against rectal cancer tumors.The early results reported so far suggest it…

A new study of an AstraZeneca PLC breast-cancer drug showed it cut the risk of tumor progression by half for people with the most advanced form of the disease, offering the prospect of a new treatment for one of the most widely diagnosed cancers.AstraZeneca and Japan’s Daiichi Sankyo Co. said Enhertu, which the drugmakers developed jointly, stopped disease progression in patients who took it in the study for an average of 9.9 months, compared with 5.1 months for…

Many cancer treatments are notoriously savage on the body. Drugs often attack both healthy cells and tumor cells, causing a plethora of side effects.Immunotherapies that help the immune system recognize and attack cancer cells are no different. Though they have prolonged the lives of countless patients, they work in only a subset of patients. One study found that fewer than 30 percent of breast cancer patients respond to one of the most common forms of immunotherapy.  But what if drugs could be engineered to attack only…